David M. Watumull

COO & CFO at Cardax

David M. Watumull has two decades of experience in astaxanthin product development, commercialization, and business management. Mr. Watumull oversees Cardax operations with responsibility for product development and manufacturing, sales and marketing, regulatory compliance, finance, and administration.


Org chart


Teams


Offices

This person is not in any offices


Cardax

Cardax (OTCQB: CDXI) is developing proprietary astaxanthin therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles.


Industries

Employees

11-50

Links